Jingze Bio

Jingze Bio is a biopharmaceutical company dedicated to the innovative research and industrialization of cutting-edge biotechnologies. It has three subsidiaries: Jiangsu Jingze, Shanghai Jingze, and Chengdu Jingze. Located in Baoshan District, Shanghai, Shanghai Jingze has built a modern drug innovation R&D platform and a pilot-scale transformation center, and is a nationally certified high-tech enterprise. Chengdu Jingze, located in Chengdu Medical City, is constructing a GMP production workshop with a scale of 4×2000L according to NMPA, FDA, and EMA standards, as well as a biopharmaceutical CDMO base that integrates process R&D, pilot production, manufacturing, and services, providing commercial production and services for domestic and international biopharmaceutical enterprises. Jingze Bio focuses on ophthalmology, reproductive health, and oncology treatment. Currently, one project has entered Phase III clinical trials, and three projects have entered Phase I clinical trials. Adhering to the vision of "Carrying forward China's heritage, benefiting all beings," the company upholds integrity and prioritizes innovation to create high-quality products that benefit patients with eye diseases and infertility.